Symbols / KMTS Stock $21.66 -2.56% Kestra Medical Technologies, Ltd.

Healthcare • Medical Instruments & Supplies • United States • NMS
KMTS (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Mr. Brian Webster
Exch · Country NMS · United States
Market Cap 1.26B
Enterprise Value 1.02B
Income -148.12M
Sales 83.72M
FCF (ttm) -74.89M
Book/sh 4.94
Cash/sh 4.99
Employees 330
Insider 10d
IPO Mar 06, 2025
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E
Forward P/E -10.12
PEG
P/S 15.10
P/B 4.39
P/C
EV/EBITDA -7.53
EV/Sales 12.18
Quick Ratio 7.08
Current Ratio 7.32
Debt/Eq 16.16
LT Debt/Eq
EPS (ttm) -5.46
EPS next Y -2.14
EPS Growth
Revenue Growth 62.70%
EPS Gr Q/Q
Rev Gr Q/Q
Earnings (next) 2026-03-17
Earnings (prior) 2026-03-17
ROA -36.84%
ROE -92.65%
ROIC
Gross Margin 48.75%
Oper. Margin -141.60%
Profit Margin -172.99%
Shs Outstand 58.37M
Shs Float 32.74M
Insider Own 5.07%
Instit Own 101.24%
Short Float 11.75%
Short Ratio 7.86
Short Interest 3.63M
52W High 30.00
vs 52W High -27.80%
52W Low 13.25
vs 52W Low 63.47%
Beta
Impl. Vol.
Rel Volume 0.63
Avg Volume 358.63K
Volume 227.01K
Target (mean) $27.71
Tgt Median $30.00
Tgt Low $17.00
Tgt High $30.00
# Analysts 7
Recom Strong_buy
Prev Close $22.23
Price $21.66
Change -2.56%
About

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company's develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its platform provides ASSURE WCD, a wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest; and a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$21.66
Low
$17.00
High
$30.00
Mean
$27.71

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-09 main Goldman Sachs Neutral → Neutral $17
2026-04-07 reit BTIG Buy → Buy $32
2026-03-25 reit BTIG Buy → Buy $32
2026-03-18 reit BTIG Buy → Buy $32
2025-12-15 main Goldman Sachs Neutral → Neutral $25
2025-12-12 main Wells Fargo Overweight → Overweight $28
2025-12-12 main Piper Sandler Overweight → Overweight $30
2025-11-18 init BTIG — → Buy $32
2025-07-17 main Wells Fargo Overweight → Overweight $27
2025-04-16 main Goldman Sachs Neutral → Neutral $23
2025-03-31 init Wolfe Research — → Outperform $29
2025-03-31 init Wells Fargo — → Overweight $28
2025-03-31 init Stifel — → Buy $28
2025-03-31 init Goldman Sachs — → Neutral $24
2025-03-31 init Piper Sandler — → Overweight $27
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-15 WEBSTER BRIAN DANIEL Chief Executive Officer 15,000 $20.04 $300,670
2026-03-26 COHEN RAYMOND W Director 10,000 $19.98 $199,800
2026-03-17 WEBSTER BRIAN DANIEL Chief Executive Officer 15,000 $20.27 $304,124
2026-03-11 REILLY KEVIN C Director 8,300 $0.00 $0
2026-02-17 WEBSTER BRIAN DANIEL Chief Executive Officer 15,000 $25.39 $384,020
2026-01-15 WEBSTER BRIAN DANIEL Chief Executive Officer 15,000 $22.80 $342,024
2025-12-29 WEBSTER BRIAN DANIEL Chief Executive Officer 15,000 $26.59 $398,847
2025-12-29 UMBERGER TRACI S General Counsel 10,500 $26.69 $280,201
2025-12-03 MORAN TIMOTHY P. Officer 19,557 $0.00 $0
2025-09-04 COHEN RAYMOND W Director 10,909 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-04-30 2024-04-30 2023-04-30 2021-04-30
Total Revenue
59.81
+115.05%
27.81
+264.53%
7.63
0.00
Operating Revenue
59.81
+115.05%
27.81
+264.53%
7.63
0.00
Cost Of Revenue
35.60
+29.70%
27.45
+50.17%
18.28
Reconciled Cost Of Revenue
35.60
+29.70%
27.45
+50.17%
18.28
Gross Profit
24.21
+6587.85%
0.36
+103.40%
-10.65
Operating Expense
130.59
+52.87%
85.42
+22.44%
69.77
+113.31%
32.71
Research And Development
15.65
+1.05%
15.49
-1.69%
15.76
-16.22%
18.81
Selling General And Administration
114.94
+64.35%
69.94
+29.48%
54.01
+288.53%
13.90
Selling And Marketing Expense
40.68
+16.50%
34.92
+151.18%
13.90
Total Expenses
166.19
+47.23%
112.88
+28.20%
88.05
+169.20%
32.71
Operating Income
-106.38
-25.06%
-85.06
-5.77%
-80.42
-145.88%
-32.71
Total Operating Income As Reported
-106.38
-25.06%
-85.06
-5.77%
-80.42
-145.88%
-32.71
EBITDA
-97.98
-28.40%
-76.31
-3.48%
-73.74
-128.11%
-32.33
Normalized EBITDA
-95.33
-24.93%
-76.31
-3.48%
-73.74
-128.11%
-32.33
Reconciled Depreciation
7.97
-31.07%
11.56
+138.11%
4.86
+1055.95%
0.42
EBIT
-105.94
-20.58%
-87.87
-11.80%
-78.59
-140.01%
-32.75
Total Unusual Items
-2.65
Total Unusual Items Excluding Goodwill
-2.65
Net Income
-113.81
-20.92%
-94.12
-11.73%
-84.24
-147.03%
-34.10
Pretax Income
-113.68
-20.81%
-94.10
-11.72%
-84.22
-148.34%
-33.91
Net Non Operating Interest Income Expense
-4.54
+27.21%
-6.23
-10.68%
-5.63
-381.93%
-1.17
Interest Expense Non Operating
7.73
+24.14%
6.23
+10.68%
5.63
+381.93%
1.17
Net Interest Income
-4.54
+27.21%
-6.23
-10.68%
-5.63
-381.93%
-1.17
Interest Expense
7.73
+24.14%
6.23
+10.68%
5.63
+381.93%
1.17
Interest Income Non Operating
3.20
0.00
Interest Income
3.20
0.00
Other Income Expense
-2.77
+1.32%
-2.80
-253.42%
1.83
+4907.89%
-0.04
Other Non Operating Income Expenses
-0.12
+95.79%
-2.80
-253.42%
1.83
+4907.89%
-0.04
Gain On Sale Of Security
-2.65
Tax Provision
0.14
+462.50%
0.02
+60.00%
0.01
-91.98%
0.19
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
-22.22%
0.00
Tax Effect Of Unusual Items
-0.56
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-113.81
-20.92%
-94.12
-11.73%
-84.24
-147.03%
-34.10
Net Income From Continuing Operation Net Minority Interest
-113.81
-20.92%
-94.12
-11.73%
-84.24
-147.03%
-34.10
Net Income From Continuing And Discontinued Operation
-113.81
-20.92%
-94.12
-11.73%
-84.24
-147.03%
-34.10
Net Income Continuous Operations
-113.81
-20.92%
-94.12
-11.73%
-84.24
-147.03%
-34.10
Minority Interests
0.69
0.00
Normalized Income
-111.72
-18.70%
-94.12
-11.73%
-84.24
-147.03%
-34.10
Net Income Common Stockholders
-126.14
-25.08%
-100.84
-16.26%
-86.74
-154.35%
-34.10
Diluted EPS
-5.13
-1.16%
-5.07
-16.26%
-4.36
-154.35%
-1.71
Basic EPS
-5.13
-1.16%
-5.07
-16.26%
-4.36
-154.35%
-1.71
Basic Average Shares
24.58
+23.63%
19.89
+0.00%
19.89
+0.00%
19.89
Diluted Average Shares
24.58
+23.63%
19.89
+0.00%
19.89
+0.00%
19.89
Diluted NI Availto Com Stockholders
-126.14
-25.08%
-100.84
-16.26%
-86.74
-154.35%
-34.10
Preferred Stock Dividends
12.32
+83.32%
6.72
+168.95%
2.50
Line Item Trend 2025-04-30 2024-04-30 2023-04-30 2021-04-30
Total Assets
295.74
+543.64%
45.95
+18.87%
38.66
+26.65%
30.52
Current Assets
255.33
+1612.81%
14.91
-19.08%
18.42
-29.67%
26.20
Cash Cash Equivalents And Short Term Investments
237.59
+2780.29%
8.25
-44.30%
14.81
-39.16%
24.34
Cash And Cash Equivalents
237.59
+2780.29%
8.25
-44.30%
14.81
-39.16%
24.34
Receivables
8.08
+304.45%
2.00
0.00
Accounts Receivable
8.08
+304.45%
2.00
0.00
Other Receivables
3.29
+55.70%
2.11
Inventory
6.57
+99.76%
3.29
+55.70%
2.11
Prepaid Assets
1.39
+45.85%
0.95
-15.84%
1.13
+122.00%
0.51
Other Current Assets
1.69
+304.06%
0.42
+13.24%
0.37
-72.49%
1.34
Total Non Current Assets
40.42
+30.20%
31.04
+53.42%
20.23
+367.71%
4.33
Net PPE
36.91
+30.00%
28.39
+69.77%
16.72
+442.43%
3.08
Gross PPE
60.86
+32.49%
45.94
+92.34%
23.88
+414.72%
4.64
Accumulated Depreciation
-23.95
-36.53%
-17.55
-145.06%
-7.16
-359.86%
-1.56
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
1.45
+0.49%
1.44
-2.18%
1.47
+63.44%
0.90
Construction In Progress
0.64
-61.75%
1.66
Other Properties
57.86
+37.94%
41.95
+94.74%
21.54
+547.62%
3.33
Leases
0.92
+3.14%
0.89
+2.18%
0.87
+110.63%
0.41
Non Current Prepaid Assets
2.02
+18.19%
1.71
-35.28%
2.64
Other Non Current Assets
1.49
+58.02%
0.94
+8.41%
0.87
-30.17%
1.24
Total Liabilities Net Minority Interest
90.34
-64.62%
255.33
+63.43%
156.23
+443.31%
28.76
Current Liabilities
37.98
+15.18%
32.97
-10.26%
36.74
+455.98%
6.61
Payables And Accrued Expenses
29.12
+8.74%
26.78
+160.96%
10.26
+84.98%
5.55
Payables
23.96
+0.29%
23.89
+287.73%
6.16
+253.93%
1.74
Accounts Payable
23.96
+0.29%
23.89
+287.73%
6.16
+262.68%
1.70
Current Accrued Expenses
5.16
+78.72%
2.88
-29.62%
4.10
+7.70%
3.81
Pensionand Other Post Retirement Benefit Plans Current
8.67
+40.02%
6.19
+32.75%
4.67
Total Tax Payable
0.23
+8.84%
0.21
+411.90%
0.04
Current Debt And Capital Lease Obligation
0.19
21.81
+1955.80%
1.06
Current Debt
20.45
Other Current Borrowings
20.45
Current Capital Lease Obligation
0.19
0.00
-100.00%
1.37
+28.75%
1.06
Other Current Liabilities
4.55
-15.27%
5.38
Total Non Current Liabilities Net Minority Interest
52.36
-76.45%
222.35
+86.08%
119.50
+439.53%
22.15
Long Term Debt And Capital Lease Obligation
44.12
-2.31%
45.17
+160.76%
17.32
-20.50%
21.79
Long Term Debt
41.10
-3.38%
42.54
+145.56%
17.32
-14.41%
20.24
Long Term Capital Lease Obligation
3.03
+14.93%
2.63
0.00
-100.00%
1.55
Other Non Current Liabilities
0.14
+84.21%
0.08
+20.63%
0.06
-82.50%
0.36
Preferred Securities Outside Stock Equity
0.00
-100.00%
177.11
+73.45%
102.11
Stockholders Equity
205.41
+198.10%
-209.38
-78.07%
-117.58
-6757.87%
1.77
Common Stock Equity
205.41
+198.10%
-209.38
-78.07%
-117.58
-6757.87%
1.77
Capital Stock
51.35
+157.92%
19.91
+1990800.00%
0.00
+0.00%
0.00
Common Stock
51.35
+157.92%
19.91
+1990800.00%
0.00
+0.00%
0.00
Share Issued
51.35
+3.66%
49.53
+0.00%
49.53
+0.00%
49.53
Ordinary Shares Number
51.35
+3.66%
49.53
+0.00%
49.53
+0.00%
49.53
Additional Paid In Capital
674.31
+280.64%
177.15
-9.03%
194.74
+13.32%
171.84
Retained Earnings
-520.25
-28.00%
-406.44
-30.14%
-312.31
-83.63%
-170.08
Total Equity Gross Minority Interest
205.41
+198.10%
-209.38
-78.07%
-117.58
-6757.87%
1.77
Total Capitalization
246.50
+247.75%
-166.84
-66.41%
-100.26
-555.63%
22.00
Working Capital
217.35
+1303.23%
-18.06
+1.38%
-18.32
-193.51%
19.59
Invested Capital
246.50
+247.75%
-166.84
-109.05%
-79.81
-462.71%
22.00
Total Debt
44.31
-1.90%
45.17
+15.42%
39.13
+71.27%
22.85
Net Debt
34.29
+49.35%
22.96
Capital Lease Obligations
3.21
+22.03%
2.63
+92.75%
1.37
-47.68%
2.61
Net Tangible Assets
205.41
+198.10%
-209.38
-78.07%
-117.58
-6757.87%
1.77
Tangible Book Value
205.41
+198.10%
-209.38
-78.07%
-117.58
-6757.87%
1.77
Derivative Product Liabilities
8.10
0.00
Line Item Trend 2025-04-30 2024-04-30 2023-04-30 2021-04-30
Operating Cash Flow
-77.61
-7.44%
-72.23
-3.72%
-69.64
-132.96%
-29.89
Cash Flow From Continuing Operating Activities
-77.61
-7.44%
-72.23
-3.72%
-69.64
-132.96%
-29.89
Net Income From Continuing Operations
-113.81
-20.92%
-94.12
-11.73%
-84.24
-147.03%
-34.10
Depreciation Amortization Depletion
7.97
-31.07%
11.56
+138.11%
4.86
+1055.95%
0.42
Depreciation
11.56
+138.11%
4.86
+1055.95%
0.42
Depreciation And Amortization
7.97
-31.07%
11.56
+138.11%
4.86
+1055.95%
0.42
Other Non Cash Items
2.67
+9.60%
2.44
-63.73%
6.72
+252.89%
1.90
Stock Based Compensation
24.27
+1531.05%
1.49
+23.08%
1.21
-35.10%
1.86
Provisionand Write Offof Assets
2.69
+438.80%
0.50
Deferred Tax
0.06
+433.33%
0.01
+126.67%
-0.04
Deferred Income Tax
0.06
+433.33%
0.01
+126.67%
-0.04
Operating Gains Losses
4.74
+137.10%
2.00
+257.14%
0.56
+1373.68%
0.04
Gain Loss On Investment Securities
2.65
0.04
Gain Loss On Sale Of PPE
2.09
+95.70%
1.07
+91.07%
0.56
Change In Working Capital
-6.20
-259.54%
3.89
+199.54%
1.30
+6931.58%
-0.02
Change In Receivables
-8.78
-251.36%
-2.50
0.00
Changes In Account Receivables
-8.78
-251.36%
-2.50
0.00
Change In Inventory
-3.44
-192.52%
-1.18
-60.57%
-0.73
Change In Prepaid Assets
-1.85
-659.52%
0.33
+222.14%
-0.27
+81.21%
-1.44
Change In Payables And Accrued Expense
7.46
-3.27%
7.71
+125.01%
3.43
+73.08%
1.98
Change In Accrued Expense
4.62
+1144.47%
0.37
-71.11%
1.28
-39.20%
2.11
Change In Payable
2.84
-61.28%
7.34
+242.51%
2.14
+1723.48%
-0.13
Change In Account Payable
2.84
-61.28%
7.34
+242.51%
2.14
+1723.48%
-0.13
Change In Other Current Assets
0.04
+500.00%
-0.01
-162.50%
0.02
-72.88%
0.06
Change In Other Current Liabilities
0.37
+178.89%
-0.47
+58.90%
-1.14
-85.23%
-0.62
Investing Cash Flow
-23.31
-90.60%
-12.23
+20.90%
-15.46
-4529.04%
-0.33
Cash Flow From Continuing Investing Activities
-23.31
-90.60%
-12.23
+20.90%
-15.46
-4529.04%
-0.33
Net PPE Purchase And Sale
-23.59
-88.52%
-12.51
+19.06%
-15.46
-4529.04%
-0.33
Purchase Of PPE
-23.59
-88.52%
-12.51
+19.06%
-15.46
-4501.49%
-0.34
Sale Of PPE
0.00
Capital Expenditure
-23.59
-88.52%
-12.51
+19.06%
-15.46
-4501.49%
-0.34
Net Other Investing Changes
0.28
-0.70%
0.28
Financing Cash Flow
330.26
+324.91%
77.72
-19.13%
96.11
+96.88%
48.81
Cash Flow From Continuing Financing Activities
330.26
+324.91%
77.72
-19.13%
96.11
+96.88%
48.81
Net Issuance Payments Of Debt
0.00
-100.00%
5.88
+210.20%
-5.33
-126.67%
20.00
Issuance Of Debt
0.00
-100.00%
45.00
0.00
-100.00%
20.00
Repayment Of Debt
0.00
+100.00%
-39.12
-633.60%
-5.33
Long Term Debt Issuance
0.00
-100.00%
45.00
0.00
-100.00%
20.00
Long Term Debt Payments
0.00
+100.00%
-39.12
-633.60%
-5.33
Net Long Term Debt Issuance
0.00
-100.00%
5.88
+210.20%
-5.33
-126.67%
20.00
Net Common Stock Issuance
215.79
0.00
Cash Dividends Paid
-1.65
-107.01%
-0.80
-19.08%
-0.67
-258.82%
-0.19
Net Other Financing Charges
12.73
+640.88%
-2.35
29.00
Changes In Cash
229.35
+3503.26%
-6.74
-161.25%
11.00
-40.80%
18.59
Beginning Cash Position
8.58
-43.98%
15.32
+254.76%
4.32
-31.09%
6.27
End Cash Position
237.93
+2672.10%
8.58
-43.98%
15.32
-38.35%
24.85
Free Cash Flow
-101.20
-19.41%
-84.75
+0.42%
-85.10
-181.51%
-30.23
Interest Paid Supplemental Data
3.63
0.00
Income Tax Paid Supplemental Data
0.04
+258.33%
0.01
-94.39%
0.21
Common Stock Issuance
215.79
0.00
Issuance Of Capital Stock
319.19
+325.59%
75.00
-26.55%
102.11
Net Preferred Stock Issuance
103.40
+37.87%
75.00
-26.55%
102.11
Preferred Stock Issuance
103.40
+37.87%
75.00
-26.55%
102.11
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category